Nexpoint Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,486
Closed -$412K 157
2022
Q1
$412K Sell
7,486
-1,837
-20% -$90.9K 0.05% 103
2021
Q4
$498K Sell
9,323
-5,500
-37% -$255K 0.07% 133
2021
Q3
$628K Hold
14,823
0.11% 96
2021
Q2
$988K Hold
14,823
0.22% 65
2021
Q1
$656K Sell
14,823
-757
-5% -$28.1K 0.17% 78
2020
Q4
$452K Hold
15,580
0.15% 111
2020
Q3
$341K Sell
15,580
-10,080
-39% -$179K 0.08% 127
2020
Q2
$297K Hold
25,660
0.07% 150
2020
Q1
$168K Sell
25,660
-306,444
-92% -$4.37M 0.03% 192
2019
Q4
$5.2M Sell
332,104
-658,200
-66% -$7.47M 0.39% 33
2019
Q3
$7.31M Buy
+990,304
New +$7.09M 0.46% 32

Other funds holding SGRY

Nexpoint Asset Management's SGRY Position: Q2 2022 in Review

Nexpoint Asset Management sold out of Surgery Partners (SGRY) in Q2 2022, closing a stake of 7,486 shares — an estimated $412K sold.

Nexpoint Asset Management first reported a position in SGRY in Q3 2019 and held it in 11 quarters. The position peaked at $7.31M in Q3 2019. 137 funds tracked by Wall St. Rank hold SGRY as of Q2 2022.

  • Nexpoint Asset Management reported no remaining Surgery Partners position as of Q2 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 7,486 Surgery Partners shares in Q2 2022, an estimated $412K.
  • Nexpoint Asset Management first reported a position in Surgery Partners in Q3 2019 and held it in 11 quarters.
  • Nexpoint Asset Management's Surgery Partners position peaked at $7.31M in Q3 2019.
  • 137 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2022.

Based on Nexpoint Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.